26
|
Rössler J, Heimpel H, Havers W. Diagnosis and clinical course of congenital dyserythropoietic anaemia type 1 in a 12-year-old girl. Eur J Pediatr 2001; 160:139-40. [PMID: 11271388 DOI: 10.1007/s004310000677] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
27
|
Breit S, Ashman K, Wilting J, Rössler J, Hatzi E, Fotsis T, Schweigerer L. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res 2000; 60:4596-601. [PMID: 10969812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
Angiogenesis, the formation of new blood vessels, is seen during embryonic development and tumor progression, but the mechanisms have remained unclear. Recent data indicate that developmental and tumor angiogenesis can be induced by cellular oncogenes, leading to the enhanced activity of molecules stimulating angiogenesis. However, activated oncogenes might also facilitate angiogenesis by down-regulating endogenous inhibitors of angiogenesis. We report here that enhanced expression of the N-myc oncogene in human neuroblastoma cells down-regulates an inhibitor of endothelial cell proliferation, identified by amino acid sequencing as being identical with activin A, a developmentally regulated protein. Down-regulation appears to involve interaction of the N-Myc protein with the activin A promoter. In addition, activin A inhibits both endothelial cell proliferation in vitro and angiogenesis in vivo, and it induces hemorrhage in vivo. We suggest that the N-myc-induced down-regulation of activin A could contribute to developmental and tumor angiogenesis.
Collapse
MESH Headings
- Activins
- Amino Acid Sequence
- Angiogenesis Inhibitors/genetics
- Angiogenesis Inhibitors/isolation & purification
- Angiogenesis Inhibitors/pharmacology
- Animals
- Cattle
- Cell Division/drug effects
- Chick Embryo
- Down-Regulation/physiology
- Endothelial Growth Factors/genetics
- Endothelial Growth Factors/isolation & purification
- Endothelium, Vascular/chemistry
- Endothelium, Vascular/drug effects
- Endothelium, Vascular/metabolism
- Gene Expression Regulation, Neoplastic/physiology
- Genes, myc/genetics
- Humans
- Inhibins/genetics
- Inhibins/isolation & purification
- Inhibins/pharmacology
- Molecular Sequence Data
- Neovascularization, Pathologic/drug therapy
- Neovascularization, Pathologic/genetics
- Neuroblastoma/blood supply
- Neuroblastoma/genetics
- Neuroblastoma/metabolism
- Recombinant Proteins/genetics
- Recombinant Proteins/pharmacology
- Sequence Homology, Amino Acid
- Transcription, Genetic/physiology
- Transfection
- Tumor Cells, Cultured
Collapse
|
28
|
Abstract
N-myc oncogene amplification is frequent in human neuroblastoma and predicts poor prognosis, but the molecular consequences have remained obscure. We report here that enhanced N-myc expression correlates with low or undetectable expression of activin A, but not other closely related members of the transforming growth factor-beta superfamily. N-myc interacts with the activin A promoter, eventually inducing down-regulation of activin A mRNA and protein. This study demonstrates for the first time N-myc-induced down-regulation of a gene implicated in signal transduction. Down-regulation of activin A could deprive neuroblastomas from a signal with growth-inhibitory activities toward the tumor and its stroma and thereby permit neuroblastoma progression.
Collapse
|
29
|
Rössler J, Havers W. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)]. KLINISCHE PADIATRIE 2000; 212:153-8. [PMID: 10994542 DOI: 10.1055/s-2000-9669] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
The congenital dyserythropoietic anemias (CDA) are hereditary diseases characterized by a lifelong, mostly moderate anemia. CDA can be diagnosed already in early childhood. However, diagnosis is complicated due to poor knowledge of morphological criteria and the large number of differential diagnoses that have to be excluded. CDA type I is characterized by macrocytic anemia with megaloblastic changes in erythropoiesis and chromatin bridges between isolated erythroblasts. Type II shows a normocytic anemia with a positive acidified serum test and increased agglutination with anti-i. Erythroblasts can present with 2 or more nuclei. CDA type III presents with a macrocytic anemia and erythroblasts with up to 12 nuclei, the so called gigantoblasts. Some patients lack the typical morphological abnormalities of type I-III (variants or type IV). Besides light microscopic abnormalities, CDA type-specific changes in electron microscopy are described. The clinical picture of the patients vary between the different forms: signs of hemolysis and ineffective erythropoiesis such as icterus, splenomegaly and gall stones can be present. Most important is the tendency of a part of patients to have an increased iron absorption and iron storage. Patients with and without transfusion dependency are described. Supportive care such as iron chelation can be necessary in some patients. The CDA are inherited in an autosomal recessive manner; in type III an additional autosomal dominant variant exists. Recently, the determination of gene loci for type I, II and III was enabled by linkage analysis on different regions of chromosome 15 and 22. It is considered that CDA I and II are genetically heterogenic. Until now no gene has been identified in either type of CDA. In CDA type II, a glycosylation defect of erythrocyte membrane proteins is present. An international group plans to do further research. Therefore, identification and registration of patients in a registry is necessary. Patients' data and material would enable gene characterization. The results would allow an extended classification according to genotype and prediction of the course of the disease. Additionally, information on the regulation and control of normal and abnormal erythropoiesis could be obtained.
Collapse
MESH Headings
- Anemia, Dyserythropoietic, Congenital/classification
- Anemia, Dyserythropoietic, Congenital/diagnosis
- Anemia, Dyserythropoietic, Congenital/genetics
- Chromosome Mapping
- Chromosomes, Human, Pair 15/genetics
- Chromosomes, Human, Pair 20/genetics
- Diagnosis, Differential
- Erythroblasts/pathology
- Genetic Predisposition to Disease/genetics
- Genotype
- Humans
- Mutation
Collapse
|
30
|
Fotsis T, Breit S, Lutz W, Rössler J, Hatzi E, Schwab M, Schweigerer L. Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells. EUROPEAN JOURNAL OF BIOCHEMISTRY 1999; 263:757-64. [PMID: 10469139 DOI: 10.1046/j.1432-1327.1999.00575.x] [Citation(s) in RCA: 46] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Recent evidence indicates that the genetic alterations of the multistage process of malignant transformation appear to activate tumor neovascularization by altering the balance between stimulators and inhibitors of angiogenesis. In the present study, we have attempted to define the effect of enhanced MYCN oncogene expression on the profile of endothelial cell growth modulators in neuroblastoma cells. We report here that conditioned medium of human neuroblastoma cells with normal MYCN expression contains three inhibitors of endothelial cell proliferation, which appear to be novel proteins as judged by their physicochemical, immunological and biological properties. All three inhibitors are diminished or become undetectable upon experimental increase of MYCN expression. Our results suggest that enhanced MYCN expression in human neuroblastoma cells alters the angiogenic balance by down-regulating endothelial cell growth inhibitors but leaving the expression of the stimulators unaffected. These data shed light on the molecular mechanisms linking the genetic changes of malignant transformation with initiation of tumor angiogenesis. Moreover, our observations might explain the poor prognosis of human neuroblastomas following MYCN oncogene amplification through initiation of angiogenesis and subsequent tumor growth and spread.
Collapse
MESH Headings
- Cell Division/drug effects
- Cell Transformation, Neoplastic
- Cells, Cultured
- Chromatography, Affinity
- Culture Media, Conditioned
- Endothelium, Vascular/cytology
- Endothelium, Vascular/drug effects
- Endothelium, Vascular/physiology
- Fibroblast Growth Factor 2/pharmacology
- Gene Expression Regulation, Neoplastic
- Genes, myc
- Growth Inhibitors/biosynthesis
- Growth Inhibitors/isolation & purification
- Humans
- Neovascularization, Pathologic
- Neuroblastoma
- Proto-Oncogene Proteins c-myc/genetics
- Recombinant Proteins/pharmacology
- Tumor Cells, Cultured
Collapse
|
31
|
Gong H, Zölzer F, von Recklinghausen G, Rössler J, Breit S, Havers W, Fotsis T, Schweigerer L. Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. Biochem Biophys Res Commun 1999; 261:10-4. [PMID: 10405315 DOI: 10.1006/bbrc.1999.1004] [Citation(s) in RCA: 62] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We have previously demonstrated that arginine deiminase inhibits the proliferation of vascular endothelial cells, but the mechanisms leading to growth inhibition have remained unclear. We report here that low concentrations of arginine deiminase purified from Mycoplasma arginini inhibit proliferation of various cultured cells by arresting the cell cycle in G(1) and/or S phase with higher arginine deiminase concentrations leading to subsequent apoptosis. Our results demonstrate that arginine deiminase inhibits cell proliferation not only by depletion of arginine, but also by mechanisms involving the cell cycle and death signals.
Collapse
|
32
|
Rössler J, Breit S, Havers W, Schweigerer L. Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia. Int J Cancer 1999. [PMID: 10077161 DOI: 10.1002/(sici)1097-0215(19990331)81:1<113::aid-ijc19>3.0.co;2-l] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Enhanced angiogenesis apparently contributes to the poor clinical outcome of human neuroblastoma, but the mechanisms have remained unclear. We report here that cultured human neuroblastoma cells express a bioactive endothelial cell growth factor indistinguishable from the angiogenesis stimulator vascular endothelial growth factor (VEGF). VEGF is present in neuroblastoma but not vascular endothelial cells, whereas the corresponding VEGF receptors (Flt-1 and Flk-1/KDR) are expressed in endothelial but not neuroblastoma cells. Exposure of neuroblastoma cells to hypoxia induces a marked increase in bioactive VEGF. VEGF is also present in human neuroblastoma specimens, with substantial amounts in apparently hypoxic neuroblastoma cells, eventually accumulating in tumor microvessels. Our results indicate that VEGF (i) is present in human neuroblastomas, (ii) is up-regulated by tumor hypoxia and (iii) may stimulate neuroblastoma angiogenesis by paracrine mechanisms, thereby contributing to the progression of human neuroblastomas. We suggest that inhibition of VEGF activity may represent a novel approach for the therapy of human neuroblastoma.
Collapse
|
33
|
Rössler J, Breit S, Havers W, Schweigerer L. Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia. Int J Cancer 1999; 81:113-7. [PMID: 10077161 DOI: 10.1002/(sici)1097-0215(19990331)81:1<113::aid-ijc19>3.0.co;2-l] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Enhanced angiogenesis apparently contributes to the poor clinical outcome of human neuroblastoma, but the mechanisms have remained unclear. We report here that cultured human neuroblastoma cells express a bioactive endothelial cell growth factor indistinguishable from the angiogenesis stimulator vascular endothelial growth factor (VEGF). VEGF is present in neuroblastoma but not vascular endothelial cells, whereas the corresponding VEGF receptors (Flt-1 and Flk-1/KDR) are expressed in endothelial but not neuroblastoma cells. Exposure of neuroblastoma cells to hypoxia induces a marked increase in bioactive VEGF. VEGF is also present in human neuroblastoma specimens, with substantial amounts in apparently hypoxic neuroblastoma cells, eventually accumulating in tumor microvessels. Our results indicate that VEGF (i) is present in human neuroblastomas, (ii) is up-regulated by tumor hypoxia and (iii) may stimulate neuroblastoma angiogenesis by paracrine mechanisms, thereby contributing to the progression of human neuroblastomas. We suggest that inhibition of VEGF activity may represent a novel approach for the therapy of human neuroblastoma.
Collapse
|
34
|
Venegas PA, Henríquez C, Rössler J. Competition between spin, charge, and bond waves in a Peierls-Hubbard model. PHYSICAL REVIEW. B, CONDENSED MATTER 1996; 54:3015-3018. [PMID: 9986188 DOI: 10.1103/physrevb.54.3015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
35
|
Külpmann WR, Rössler J, Brunkhorst R, Schüler A. Ionised and total magnesium serum concentrations in renal and hepatic diseases. EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY : JOURNAL OF THE FORUM OF EUROPEAN CLINICAL CHEMISTRY SOCIETIES 1996; 34:257-64. [PMID: 8721414 DOI: 10.1515/cclm.1996.34.3.257] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Ionised and total magnesium concentrations were determined in the serum of different groups of patients suffering from renal or hepatic diseases. Ionised magnesium was measured by Microlyte 6 (KONE, Espoo, Finland) and total magnesium by atomic absorption spectrometry. In renal insufficiency ionised and total magnesium concentrations were almost equally increased. In proteinuria with a normal glomerular filtration rate, "pseudohypomàgnesaemia" was observed, i.e. decreased total magnesium concentration in parallel with a decreased albumin concentration with no significant change in the concentration of ionised magnesium. Hypermagnesaemia occurred in liver diseases combined with renal insufficiency, whereas "pseudohypomagnesaemia" was most often found in the absence of renal failure. Also treatment with an aldosterone antagonist was associated with a normal ionised magnesium concentration, but the total magnesium concentration was decreased; when additional magnesium was administered, the total magnesium concentration approached a normal value, while ionised magnesium slightly exceeded reference values. Only during cyclosporin treatment did both ionised and total magnesium concentrations become lowered. However, the decrease of total magnesium exceeded that of ionised magnesium due to concomitant hypoalbuminaemia with reduction of the protein-bound fraction. It is concluded that especially low total magnesium concentrations should be investigated by measurement of ionised magnesium to exclude "pseudohypomagnesaemia".
Collapse
|
36
|
Cardenas M, Gottlieb D, Rössler J. Exact and adiabatic solutions for a spinless Peierls-Hubbard model in a finite cluster. PHYSICAL REVIEW. B, CONDENSED MATTER 1993; 48:10719-10727. [PMID: 10007369 DOI: 10.1103/physrevb.48.10719] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
37
|
Westarp ME, Bartmann P, Rössler J, Geiger E, Westphal KP, Schreiber H, Fuchs D, Westarp MP, Kornhuber HH. Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. Neuroreport 1993; 4:819-22. [PMID: 8394159 DOI: 10.1097/00001756-199306000-00056] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Clinical and experimental findings in idiopathic amyothrophic lateral sclerosis (ALS) would be compatible with a retroviral involvement. In 35 adult patients with non-familial ALS we observed elevated circulating immune complexes, a decrease in IgG3 isotype and enzyme-linked sorbent assay (ELISA) serum antibodies against human spuma retrovirus (HSRV), confirmed by specific human foamy virus immunoblots. All 35 were negative for IgM or relevant IgG anti-ganglioside antibodies. We treated 12 HIV-negative, immune-complex-positive ALS patients with 500 mg d-1 zidovudine p.o. over 2-10 months and found reductions of serum creatine kinase and circulating immune complexes from two days to two weeks after the beginning of medication.
Collapse
|
38
|
Mahnke C, Kashaiya P, Rössler J, Bannert H, Levin A, Blattner WA, Dietrich M, Luande J, Löchelt M, Friedman-Kien AE. Human spumavirus antibodies in sera from African patients. Arch Virol 1992; 123:243-53. [PMID: 1314048 DOI: 10.1007/bf01317261] [Citation(s) in RCA: 30] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Serum samples collected from patients with a wide variety of diseases from African and other countries were tested for antibodies to the human spumaretrovirus (HSRV). A spumaviral env-specific ELISA was employed as screening test. Out of 3020 human sera screened, 106 were found to be positive (3.2%). While the majority of patients' sera from Europe (1581) were negative, 26 were positive (1.6%). Sera from healthy adult blood donors (609), from patients with multiple sclerosis (48), Graves' disease (45), and chronic fatigue syndrome (41) were negative or showed a very low prevalence for spumaviral env antibodies. A higher percentage of seropositives (6.3%) were found among 1338 African patients from Tanzania, Kenya, and Gabon. Out of 1180 patients from Tanzania, 708 suffered from tumors, 75 from AIDS, and 128 had gynecological problems; 51 of the Tanzanian patients were HSRV seropositive (4.3%). A particularly high percentage of 16.6% seropositives were identified among nasopharyngeal carcinoma patients (NPC) from Kenya and Tanzania consistent with results reported 10 years ago. However, 20 nasopharyngeal carcinoma patients from Malaysia were HSRV-seronegative. In selected cases, sera from seropositive individuals were reacted with proteins from HSRV-infected cells in vitro. HSRV env- and gag-specific antibodies were specifically detected by these sera in Western blots. The results indicate spumavirus infections in human patients with various diseases at a relatively low prevalence worldwide; in African patients, however, the prevalence of spumavirus infections is markedly higher.
Collapse
|
39
|
Rivas M, Rössler J, Kiwi M. Electron-phonon coupling in mixed-valence systems. PHYSICAL REVIEW. B, CONDENSED MATTER 1991; 43:3593-3600. [PMID: 9997675 DOI: 10.1103/physrevb.43.3593] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
40
|
Balatka J, Kokstein Z, Soulek V, Vondruska V, Rössler J. [The Romano-Ward syndrome imitating epilepsy in a 10-year-old boy]. CESKOSLOVENSKA PEDIATRIE 1989; 44:719-20. [PMID: 2636557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
41
|
Rössler J, Kiwi M, Hess B, Markus M. Modulated nonlinear processes and a novel mechanism to induce chaos. PHYSICAL REVIEW. A, GENERAL PHYSICS 1989; 39:5954-5960. [PMID: 9901181 DOI: 10.1103/physreva.39.5954] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
42
|
Hentschel F, Klein M, Walther J, Rössler J. [Symptomatology of intracranial vascular ectasias]. PSYCHIATRIE, NEUROLOGIE, UND MEDIZINISCHE PSYCHOLOGIE 1984; 36:41-6. [PMID: 6709765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
The ectasia of intracranial arteries shows a versatile neurological picture containing all symptoms from paraphrased deficiency of brain nerves and vegetative imbalances until the suspicion of a tumor cerebri. Two cases of our own are represented and compared with data in literature also referring on their etiology.
Collapse
|
43
|
Lütgemeier I, Lütgemeier J, Rössler J, Grumbrecht C. [Psychological examination on the desire of the patient for knowledge and information]. DIE MEDIZINISCHE WELT 1981; 32:1760-3. [PMID: 7311785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
44
|
Lütgemeier I, Rössler J, Lütgemeier J, Hörst M. [Treatment procrastination time in breast cancer and personality structure]. ONKOLOGIE 1979; 2:152-5. [PMID: 392383 DOI: 10.1159/000214581] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Sixty patients with mammary cancer were studied in order to determine whether a connection between the tendency to delay medical treatment and a neurotic personality structure exists. The results are based on different personality factors that were investigated by means of the 16-PF test by Cattell. It could be shown that for patients who had delayed treatment (D2) the personality traits "limited inner tension" and "slightly inhibited" were present. On the other hand patients who had not delayed treatment (K1) displayed the personality traits "higher inner tension" and "free of inhibitions".
Collapse
|
45
|
Frank M, Rössler J, Hlava A. [Atypical form of Fallot's tetralogy]. CESKOSLOVENSKA PEDIATRIE 1975; 30:412-4. [PMID: 1204115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
46
|
Rössler J, Endrys J. [Exchange transfusion by femoral vein or artery]. CESKOSLOVENSKA PEDIATRIE 1975; 30:119-21. [PMID: 1170029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
47
|
Paces V, Capek J, Rössler J. [Uretero-calicoanstomosis by Neuwirt's method]. ROZHLEDY V CHIRURGII : MESICNIK CESKOSLOVENSKE CHIRURGICKE SPOLECNOSTI 1974; 53:411-4. [PMID: 4847417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
48
|
Procházka J, Rössler J, Hlava A, Jurin I. [Rupture of the Valsalva's sinus]. ROZHLEDY V CHIRURGII : MESICNIK CESKOSLOVENSKE CHIRURGICKE SPOLECNOSTI 1974; 53:234-9. [PMID: 4845058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
49
|
Endrys J, Yousof AM, Rössler J, Frank M. Percutaneous catheterization in infants and newborns. Singapore Med J 1973; 14:250-1. [PMID: 4777870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
50
|
Endrys J, Yousuf AM, Rössler J, Frank M. [Percutaneous heart catherization and angiocardiography in 62 children up to 10 kg of body weight]. ROZHLEDY V CHIRURGII : MESICNIK CESKOSLOVENSKE CHIRURGICKE SPOLECNOSTI 1973; 52:4-9. [PMID: 4686755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|